New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study  
11/8/2012 7:38:42 AM

Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential new drug target for treating CF lung disease, which is a major cause of illness and death for people with CF.